Normal tissue and tumor microenvironment adaptations to aerobic exercise enhance doxorubicin anti-tumor efficacy and ameliorate its cardiotoxicity in retired breeder mice
Normal tissue and tumor microenvironment adaptations to aerobic exercise enhance doxorubicin anti-tumor efficacy and ameliorate its cardiotoxicity in retired breeder mice |
|
https://doi.org/10.18632/oncotarget.28057
Zachary R. Wakefield,
Mai Tanaka,
Christine Pampo,
Sharon Lepler,
Lori Rice,
Joy Guingab-Cagmat,
Timothy J. Garrett,
and Dietmar W. Siemann
|
| 1737-1748 |
Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status
Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status |
|
https://doi.org/10.18632/oncotarget.28047
Hélène Marijon,
Sigal Gery,
Hua Chang,
Yosef Landesman,
Sharon Shacham,
Dhong Hyun Lee,
Aimery de Gramont,
and Harold Phillip Koeffler
|
| 1749-1762 |
Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by topoisomerase 2 inhibitors in cells with FLT3 internal tandem duplication
Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by topoisomerase 2 inhibitors in cells with FLT3 internal tandem duplication |
|
https://doi.org/10.18632/oncotarget.28042
Mario Scarpa,
Shivani Kapoor,
Eric S. Tvedte,
Kshama A. Doshi,
Ying S. Zou,
Prerna Singh,
Jonelle K. Lee,
Aditi Chatterjee,
Moaath K. Mustafa Ali,
Robin E. Bromley,
Julie C. Dunning Hotopp,
Feyruz V. Rassool,
and Maria R. Baer
|
| 1763-1779 |
Impact factor and citation metrics in phase III cancer trials
Impact factor and citation metrics in phase III cancer trials |
|
https://doi.org/10.18632/oncotarget.28044
Joseph Abi Jaoude,
Ramez Kouzy,
Michael Rooney,
Petria Thompson,
Roshal Patel,
Maddie C. Turner,
Marc Ghabach,
C. David Fuller,
Bruce D. Minsky,
Cullen M. Taniguchi,
and Ethan B. Ludmir
|
| 1780-1786 |
Inhibition of the MAP2K7-JNK pathway with 5Z-7-oxozeaenol induces apoptosis in T-cell acute lymphoblastic leukemia
Inhibition of the MAP2K7-JNK pathway with 5Z-7-oxozeaenol induces apoptosis in T-cell acute lymphoblastic leukemia |
|
https://doi.org/10.18632/oncotarget.28040
Taylor J. Chen,
Wa Du,
Jacob J. Junco,
Cory Seth Bridges,
Ye Shen,
Monica Puppi,
Karen R. Rabin,
and H. Daniel Lacorazza
|
| 1787-1801 |
Correlation between PD-L1 expression and MET gene amplification in patients with advanced non-small cell lung cancer and no other actionable oncogenic driver
Correlation between PD-L1 expression and MET gene amplification in patients with advanced non-small cell lung cancer and no other actionable oncogenic driver |
|
https://doi.org/10.18632/oncotarget.28045
Marta Domènech,
Ana M. Muñoz Marmol,
Jose Luis Mate,
Anna Estival,
Teresa Moran,
Marc Cucurull,
Maria Saigi,
Ainhoa Hernandez,
Carolina Sanz,
Alba Hernandez-Gallego,
Aintzane Urbizu,
Anna Martinez-Cardus,
Adrià Bernat,
and Enric Carcereny
|
| 1802-1810 |
Effect of hypertension and medication use regularity on postoperative delirium after maxillofacial tumors radical surgery
Effect of hypertension and medication use regularity on postoperative delirium after maxillofacial tumors radical surgery |
|
https://doi.org/10.18632/oncotarget.28048
Shuyi Kong,
Jing Wang,
Hui Xu,
and Kaiqiang Wang
|
| 1811-1820 |
Anti-aging: senolytics or gerostatics (unconventional view)
Anti-aging: senolytics or gerostatics (unconventional view) |
|
https://doi.org/10.18632/oncotarget.28049
Mikhail V. Blagosklonny
|
| 1821-1835 |
The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series
The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series |
|
https://doi.org/10.18632/oncotarget.28046
Kevin Drenner,
Gargi D. Basu,
Laurie J. Goodman,
Audrey A. Ozols,
Janine R. LoBello,
Thomas Royce,
Michael S. Gordon,
Erkut H. Borazanci,
Margaux A. Steinbach,
Jeffrey Trent,
and Sunil Sharma
|
| 1836-1847 |
Juvenile polyposis without a germline variant in SMAD4/BMPR1A: defining a clinically distinct polyposis syndrome
Juvenile polyposis without a germline variant in SMAD4/BMPR1A: defining a clinically distinct polyposis syndrome |
|
https://doi.org/10.18632/oncotarget.27999
Suzanne P. MacFarland,
and Bryson W. Katona
|
| 1848-1849 |
Targeting cancer stem cells via integrin β4
Targeting cancer stem cells via integrin β4 |
|
https://doi.org/10.18632/oncotarget.27977
Hannah E. Dobson,
Shasha Ruan,
Alfred E. Chang,
Max S. Wicha,
and Qiao Li
|
| 1850-1858 |
Correction: MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression
Correction: MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression |
|
https://doi.org/10.18632/oncotarget.28066
Ming-Hua Hu,
Chen-Yang Ma,
Xiao-Ming Wang,
Chen-Dong Ye,
Guang-Xian Zhang,
Lin Chen,
and Jin-Guo Wang
|
| 1859-1860 |
